Recalls / Firms / STAQ Pharma, Inc.
STAQ Pharma, Inc.
6 FDA drug recalls on record — 2 Class I.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2025-10-09 | Class III | Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, | Ongoing |
| 2025-10-09 | Class III | Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pha | Ongoing |
| 2025-10-09 | Class III | FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, | Ongoing |
| 2023-11-29 | Class II | ROPivacaine HCl 0.2% PF in Sodium Chloride 1,000 mg/500 mL (2 mg per mL) Injection, 500 mL | Completed |
| 2022-02-03 | Class I | HYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in NaCl, 50 mL in 50 mL Single Dose Syringe, R | Terminated |
| 2022-02-03 | Class I | Morphine Sulfate PF 25 mg/25mL (1 mg/mL) in NaCl, 25 mL in 30 mL Single Dose Syringe, Rx o | Terminated |